News

23andMe’s genetic database provided the necessary samples for the latest study related to genetic prerequisites for low bone density and the development of osteoporosis. The main goal of the study was to find the causal connection between the genetic variations and the illness and help develop potential treatments and identify patients earlier.

After clearing its test for three variants in BRCA1 and BRCA2 genes related to breast cancer, the FDA has also greenlit 23andMe’s test for two variants that influence MUTYH-associated polyposis. This is a rare condition that generally increases the risk of developing colorectal cancer. Learn more about this test in our report.

23andMe has partnered with Lark Health to incorporate 8 health-related reports into its wellness AI-based coach app in order to help people lose weight based on their genetics. Learn more in this article.

Embark Dog DNA Test has officially made it to this year’s Oprah’s Favorite Things gift list and it is featured in the December issue of O, The Oprah Magazine. Read this article to learn more about Embark and find out how you can win some or even all the items on this list packed with crazy gadgets, delicious cakes, and more.

23andMe’s Personal Genome Service Pharmacogenetic Reports test just got approved by the FDA. The first direct-to-customer screening option of its kind to secure FDA approval, the test is designed to detect potential genetic variants in charge of one’s ability to metabolize certain medications. Learn more about this big win for 23andMe in this article.

Embark has published its first scientific research, which conveys the company’s commitment to ending all preventable diseases in dogs. The project, which is the biggest initiative of its kind to date, was launched to answer why some dogs have blue eyes. Learn more about this exciting genome-wide association study in this article.

Ancestry recently updated its algorithm in an effort to provide more precise ethnicity estimates. While it seems that the majority of users are satisfied with the changes, some customers are disappointed in the DNA testing giant. Read our report to learn more about the backlash Ancestry is currently facing.

Ancestry, the leader in the field of genetic genealogy, has turned its 30-year experience into actionable data that will provide its existing and future users with much more precise ethnic estimates. Read all about this major algorithm update here and learn how to connect with your true genetic roots anywhere in the world.

MyHeritage’s free upload service just got an upgrade. As of September 12, 2018, users can upload tests based on the Global Screening Array chip, including 23andMe v5 and Living DNA tests. By uploading their DNA data now, users get to enjoy full access to multiple exciting MyHeritage features free of charge. Find out more in our detailed report.

23andMe is severely limiting access to its rich database by disabling its API (application programming interface). This move will have great repercussions on dozens of app developers currently using the data to work on their software. Read all about this decision and find out what the company’s representatives had to say about it.